Loading...

AmeriCann

OTCPK:ACAN
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ACAN
OTCPK
$43M
Market Cap
  1. Home
  2. US
  3. Commercial Services
Company description

AmeriCann, Inc. designs, develops, and owns medical cannabis facilities to produce the medical cannabis in the United States. The last earnings update was 30 days ago. More info.


Add to Portfolio Compare Print
ACAN Share Price and Events
7 Day Returns
4.4%
OTCPK:ACAN
1.4%
US Professional Services
1.2%
US Market
1 Year Returns
-19%
OTCPK:ACAN
6.8%
US Professional Services
3%
US Market
ACAN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
AmeriCann (ACAN) 4.4% 0.5% 0% -19% 370% -
US Professional Services 1.4% 2.6% 20.9% 6.8% 35.1% 47.4%
US Market 1.2% 2.1% 14.6% 3% 39% 43.5%
1 Year Return vs Industry and Market
  • ACAN underperformed the Professional Services industry which returned 6.8% over the past year.
  • ACAN underperformed the Market in United States of America which returned 3% over the past year.
Price Volatility
ACAN
Industry
5yr Volatility vs Market

ACAN Value

 Is AmeriCann undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for AmeriCann. This is due to cash flow or dividend data being unavailable. The share price is $1.88.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for AmeriCann's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are AmeriCann's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:ACAN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.17
OTCPK:ACAN Share Price ** OTCPK (2019-03-20) in USD $1.88
United States of America Professional Services Industry PE Ratio Median Figure of 35 Publicly-Listed Professional Services Companies 22.84x
United States of America Market PE Ratio Median Figure of 3,058 Publicly-Listed Companies 17.69x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of AmeriCann.

OTCPK:ACAN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:ACAN Share Price ÷ EPS (both in USD)

= 1.88 ÷ -0.17

-10.91x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • AmeriCann is loss making, we can't compare its value to the US Professional Services industry average.
  • AmeriCann is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does AmeriCann's expected growth come at a high price?
Raw Data
OTCPK:ACAN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -10.91x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Professional Services Industry PEG Ratio Median Figure of 32 Publicly-Listed Professional Services Companies 1.59x
United States of America Market PEG Ratio Median Figure of 2,103 Publicly-Listed Companies 1.48x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for AmeriCann, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on AmeriCann's assets?
Raw Data
OTCPK:ACAN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.33
OTCPK:ACAN Share Price * OTCPK (2019-03-20) in USD $1.88
United States of America Professional Services Industry PB Ratio Median Figure of 56 Publicly-Listed Professional Services Companies 2.38x
United States of America Market PB Ratio Median Figure of 5,156 Publicly-Listed Companies 1.89x
OTCPK:ACAN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:ACAN Share Price ÷ Book Value per Share (both in USD)

= 1.88 ÷ 0.33

5.75x

* Primary Listing of AmeriCann.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • AmeriCann is overvalued based on assets compared to the US Professional Services industry average.
X
Value checks
We assess AmeriCann's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Professional Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Professional Services industry average (and greater than 0)? (1 check)
  5. AmeriCann has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

ACAN Future Performance

 How is AmeriCann expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as AmeriCann has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.1%
Expected Professional Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is AmeriCann expected to grow at an attractive rate?
  • Unable to compare AmeriCann's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare AmeriCann's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare AmeriCann's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:ACAN Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Professional Services Industry Earnings Growth Rate Market Cap Weighted Average 21.1%
United States of America Professional Services Industry Revenue Growth Rate Market Cap Weighted Average 5.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:ACAN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:ACAN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 -2 -4
2018-09-30 -2 -4
2018-06-30 0 -2 -5
2018-03-31 0 -2 -4
2017-12-31 0 -2 -4
2017-09-30 0 -2 -3
2017-06-30 0 -2 -3
2017-03-31 0 -2 -3
2016-12-31 0 -1 -2
2016-09-30 0 -1 -2
2016-06-30 0 -1 -2
2016-03-31 0 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if AmeriCann is high growth as no earnings estimate data is available.
  • Unable to determine if AmeriCann is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:ACAN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from AmeriCann Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:ACAN Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.17
2018-09-30 -0.22
2018-06-30 -0.25
2018-03-31 -0.21
2017-12-31 -0.19
2017-09-30 -0.15
2017-06-30 -0.14
2017-03-31 -0.14
2016-12-31 -0.13
2016-09-30 -0.13
2016-06-30 -0.11
2016-03-31 -0.11

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if AmeriCann will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine AmeriCann's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. AmeriCann's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Commercial Services companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access AmeriCann's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess AmeriCann's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
AmeriCann has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

ACAN Past Performance

  How has AmeriCann performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare AmeriCann's growth in the last year to its industry (Professional Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • AmeriCann does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare AmeriCann's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare AmeriCann's 1-year growth to the US Professional Services industry average as it is not currently profitable.
Earnings and Revenue History
AmeriCann's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from AmeriCann Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:ACAN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 -3.60 1.80
2018-09-30 -4.43 2.03
2018-06-30 0.00 -4.86 2.08
2018-03-31 0.01 -4.04 2.04
2017-12-31 0.03 -3.63 1.98
2017-09-30 0.04 -2.77 1.84
2017-06-30 0.03 -2.67 1.47
2017-03-31 0.06 -2.56 1.35
2016-12-31 0.06 -2.34 1.23
2016-09-30 0.06 -2.21 1.19
2016-06-30 0.09 -1.84 1.80
2016-03-31 0.09 -1.80 1.87
2015-12-31 0.13 -1.88 2.04
2015-09-30 0.14 -1.73 1.95
2015-06-30 0.16 -1.21 1.47
2015-03-31 0.11 -1.78 1.99
2014-12-31 0.06 -1.54 1.66
2014-09-30 0.03 -1.30 1.36
2014-06-30 -1.01 1.02
2014-03-31 -0.14 0.15
2013-12-31 0.00 0.02
2013-09-30 0.00 0.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if AmeriCann has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if AmeriCann has efficiently used its assets last year compared to the US Professional Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if AmeriCann improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess AmeriCann's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Professional Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
AmeriCann has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

ACAN Health

 How is AmeriCann's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up AmeriCann's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • AmeriCann is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • AmeriCann has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of AmeriCann's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from AmeriCann Company Filings, last reported 2 months ago.

OTCPK:ACAN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 7.45 2.39 0.07
2018-09-30 6.83 2.30 0.20
2018-06-30 3.40 2.49 1.01
2018-03-31 2.61 2.74 0.39
2017-12-31 2.57 2.41 0.73
2017-09-30 2.28 3.05 0.00
2017-06-30 3.34 2.97 0.01
2017-03-31 3.43 2.98 0.20
2016-12-31 3.69 2.98 0.80
2016-09-30 0.61 3.18 0.00
2016-06-30 0.39 3.42 0.01
2016-03-31 0.73 2.93 0.06
2015-12-31 0.98 2.76 0.04
2015-09-30 1.31 2.58 0.20
2015-06-30 2.06 2.16 0.10
2015-03-31 2.33 2.07
2014-12-31 2.51 0.81 0.07
2014-09-30 2.64 0.84 0.17
2014-06-30 0.47 0.01 0.03
2014-03-31 0.59 0.01 0.57
2013-12-31 -0.01 0.01
2013-09-30 0.00 0.00
  • AmeriCann's level of debt (32.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (591.4% vs 32.1% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • AmeriCann has less than a year of cash runway based on current free cash flow.
  • AmeriCann has less than a year of cash runway if free cash flow continues to grow at historical rates of 44.9% each year.
X
Financial health checks
We assess AmeriCann's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. AmeriCann has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

ACAN Dividends

 What is AmeriCann's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from AmeriCann dividends.
If you bought $2,000 of AmeriCann shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate AmeriCann's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate AmeriCann's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:ACAN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Professional Services Industry Average Dividend Yield Market Cap Weighted Average of 20 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2004 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as AmeriCann has not reported any payouts.
  • Unable to verify if AmeriCann's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of AmeriCann's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as AmeriCann has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess AmeriCann's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can AmeriCann afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. AmeriCann has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

ACAN Management

 What is the CEO of AmeriCann's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Tim Keogh
COMPENSATION $144,000
AGE 38
TENURE AS CEO 5 years
CEO Bio

Mr. Timothy Ryan Keogh, also known as Tim, has been the Chief Executive Officer of Americann, Inc. since March 25, 2014 and serves as its President. Prior to joining AmeriCann, Mr. Keogh was the Chief Executive Officer and a director of Coastal Compassion, Inc. From November 2010 to November 2013, Mr. Keogh owned and managed Dock Promotions, LLC. From 2003 to 2010, Mr. Keogh served as the Director of Business Services for Marina Management Services, Inc., a corporation which provided management & consulting solutions to waterfront developments, marinas and boatyards throughout the Americas and the Caribbean. Mr. Keogh is a founder of the Cannabis Producers Association of New England, an advisory board member of the Rhode Island Patient Advocacy Coalition and an active member and invited speaker for the National Cannabis Industry Association. Mr. Keogh has been a Director of Americann, Inc. since March 25, 2014. Mr. Keogh holds a Bachelor of Science in Business Administration from Mount St. Mary's College.

CEO Compensation
  • Tim's compensation has been consistent with company performance over the past year.
  • Tim's remuneration is lower than average for companies of similar size in United States of America.
Management Team

Tim Keogh

TITLE
CEO, President & Director
COMPENSATION
$144K
AGE
38
TENURE
5 yrs

Ben Barton

TITLE
Founder
AGE
53

Brian Corr

TITLE
Director of Horticultural Science & Operations and Member of Advisory Board
TENURE
1.8 yrs

Rien Havens

TITLE
Extraction & Infused Product Advisor and Member of Advisory Board

Eric Forington

TITLE
Genetics & Breeding Advisor and Member of Advisory Board

D. Anderson

TITLE
Medical Advisor & Member of Advisory Board

Nick Brait

TITLE
Licensing & Compliance Advisor and Member of Advisory Board
Board of Directors Tenure

Average tenure and age of the AmeriCann board of directors in years:

4.2
Average Tenure
38
Average Age
  • The tenure for the AmeriCann board of directors is about average.
Board of Directors

Tim Keogh

TITLE
CEO, President & Director
COMPENSATION
$144K
AGE
38
TENURE
5 yrs

Ben Barton

TITLE
Founder
AGE
53
TENURE
5.2 yrs

Brian Corr

TITLE
Director of Horticultural Science & Operations and Member of Advisory Board

Rien Havens

TITLE
Extraction & Infused Product Advisor and Member of Advisory Board
TENURE
3.3 yrs

Eric Forington

TITLE
Genetics & Breeding Advisor and Member of Advisory Board

D. Anderson

TITLE
Medical Advisor & Member of Advisory Board

Nick Brait

TITLE
Licensing & Compliance Advisor and Member of Advisory Board

J. Opel

TITLE
Director
AGE
29
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess AmeriCann's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. AmeriCann has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

ACAN News

Simply Wall St News

ACAN Company Info

Description

AmeriCann, Inc. designs, develops, and owns medical cannabis facilities to produce the medical cannabis in the United States. It partners with local businesses to serve marijuana patients in their communities. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was founded in 2010 and is based in Denver, Colorado.

Details
Name: AmeriCann, Inc.
ACAN
Exchange: OTCPK
Founded: 2010
$43,058,796
22,903,615
Website: http://www.americann.co
Address: AmeriCann, Inc.
1550 Wewatta Street,
Denver,
Colorado, 80202,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK ACAN Common Stock Pink Sheets LLC US USD 11. Sep 2013
Number of employees
Current staff
Staff numbers
3
AmeriCann employees.
Industry
Research and Consulting Services
Commercial Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/21 00:29
End of day share price update: 2019/03/20 00:00
Last earnings filing: 2019/02/19
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/09/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.